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Protein restriction during lactation has been used as a rat model of metabolic programming to study the impact
of perinatal malnutrition on adult metabolism. In contrast to protein restriction during fetal life, protein restriction
during lactation did not appear to cause either obesity or the hallmarks of metabolic syndrome, such as
hyperinsulinemia, when individuals reached adulthood. However, protein restriction provokes body underweight
and hypoinsulinemia. This review is focused on the regulation of insulin secretion and the influence of the
autonomic nervous system (ANS) in adult rats that were protein-malnourished during lactation. The data available
on the topic suggest that the perinatal phase of lactation, when insulted by protein deficit, imprints the adult
metabolism and thereby alters the glycemic control. Although hypoinsulinemia programs adult rats to maintain
normoglycemia, pancreatic β-cells are less sensitive to secretion stimuli, such as glucose and cholinergic agents.
These pancreatic dysfunctions may be attributed to an imbalance of ANS activity recorded in adult rats that
experienced maternal protein restriction.
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The developmental origins of health and disease
(DOHaD) hypothesis, which stipulates that adult meta-
bolic disease may be programmed during the perinatal
stage, has been tested in several experimental animal
models. A large amount of evidence suggests that the
etiology of obesity is not only related to food abundance
but also to food restriction during early life [1-5]. There
are numerous data showing that nutrient deprivation to
the fetus increases the risk of developing metabolic dis-
ease in adult life [6,7]. Lactation, similarly to uterine life,
is a very important phase for brain development, in
rodent species in particular and, thus, constitutes another
sensitive window during which nutritional insults can lead
to the programming of adult metabolic disease [8,9].
Indeed, over nutrition during lactation provokes obesity
and hyperinsulinemia, among other hallmarks of metabolic* Correspondence: pmathias@uem.br
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distribution, and reproduction in any mediumsyndrome, whereas under nutrition permanently decreases
body weight and causes metabolic changes. Because
insulin plays a key role in the genesis of metabolic dis-
ease, this review will be dedicated to the effects of mal-
nutrition during lactation on the regulation of insulin
secretion via putative modifications of the autonomic
nervous system (ANS).Autonomic nervous system and metabolism
One of the remarkable roles of the ANS is to help the
central nervous system regulate the metabolism. Func-
tioning as a bi-directional data conduit, afferent and
efferent trunk nerves inform the brain regarding the per-
ipheral metabolic status and return signals to the differ-
ent tissues to maintain the metabolic homeostasis,
respectively. The electrical stimulation of the ventro-
medial hypothalamic nucleus induces the immediate
activation of hepatic glycogenolysis [10], whereas the
stimulation of the lateral hypothalamus leads to a
prompt enhancement of glycogen synthesis that allows
an increase in blood glucose levels [11]. Both effects are
mediated by the ANS and by the sympathetic andtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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senses glucose production in the liver and sends signals
to the central nervous system, which integrates this mes-
sage to control the metabolism [13]. Indeed, central and
peripheral neural signals contribute to the control of the
blood glucose concentration and to the maintenance of
the body energy homeostasis. These neural mechanisms
are thus pivotal to the regulation of body weight. The
neural control of blood glucose levels also involved
many endocrine factors, particularly those released by
the pancreas and the adrenal medulla. During fasting
and feeding sessions, the sympathetic and parasympa-
thetic nervous system (PNS) activities adapt to maintain
normoglycemia. A network of ANS neurons acting on
target endocrine cells stimulates or inhibits the release
of these hormones [14]. Postprandial hyperglycemia
induces an increase in the PNS activity, which, through-
out the vagal ends, potentiates glucose-induced insulin
release from the pancreatic β-cells. This rise in the insu-
lin levels rapidly provokes a fall in the blood glucose
levels. However, the sympathetic nervous system,
through the impulses of the splanchnic neurons, stimu-
lates the adrenal medulla chromaffin cells to secrete
catecholamines (mostly adrenaline) that increase the
blood glucose concentration by hepatic glucose produc-
tion and by blocking insulin secretion [15]. The elec-
trical stimulation of the vagus or the splanchnic nerve
alters the insulin or glucagon output from the pancreas,
respectively [16]. The deterioration of these mechanisms
thus might also be involved in the modulation of body
weight [17-19].
Much attention has been paid to insulin over secre-
tion, which is observed in obesity. An imbalance of ANS
activity has been suggested as one cause, among others,
of this pancreatic β-cell dysfunction. In obese humans
and rodents, high vagus nerve activity has been
observed, whereas reduced sympathetic tonus has been
reported [20-23]. However, although less attention has
been focused on the pathophysiology of the onset of
body underweight, several studies have reported that
the ANS activity is altered in under- or malnourished
organisms [24,25]. After weaning, rats fed a chronically
protein-deficient diet exhibited low activity of the vagus
nerve, whereas high sympathetic activity was recorded,
and these data were in agreement with a low insulin
response to glucose [25]. In another study, pancreatic
islets isolated from protein-restricted rats showed weak
glucose and cholinergic insulin tropic responses [24],
suggesting that the pancreatic β-cell dysfunction may be
attributed to altered ANS activity in these underweight
animals, as represented in schematic Figure 1.
Food abundance or restriction with regard to body
weight control involves changes in metabolic homeosta-
sis and ANS balance activity. Although the secretion ofinsulin by the pancreatic β-cells is increased in people
who were overweight, it is diminished in people who
were underweight. Changes in the ANS activity may con-
stitute the mechanisms underlying the β-cell dysfunction:
the high PNS tonus observed in obese individuals con-
stantly potentiates insulin secretion, whereas the low
activity reported in underweight individuals is associated
with a weak cholinergic insulin tropic effect [26].
With the growing worldwide obesity epidemic, includ-
ing huge populations in developing countries, such as
China, India, Mexico and Brazil, the causes of this health
and economic catastrophe have been increasingly stud-
ied [27-30]. It is well known that metabolic syndrome
and obesity exhibit a high correlation with low or absent
physical exercise practices and the consumption of
calorie-rich diets in developing countries; however, al-
though the inhabitants may actually experience a nutri-
tion transition, high levels of overweight and obese
individuals could not be justified solely by diet and phys-
ical inactivity, other hallmarks, such as metabolic pro-
gramming by the under nutrition early in life and
epigenetic modification could also be underlining the
obesity onset.
Under nutrition early in life and epigenetic modifications,
association with metabolic diseases risk
In addition to the pathophysiological aspects that have
emerged from studies on metabolic programming caused
by environmental insults during fetal life [31,32], another
interesting point that is relevant to this issue is the
role of epigenetic changes in the increased risk of devel-
oping metabolic diseases, such as type 2 diabetes and
obesity, later in life. Epigenetic mechanisms, such as
DNA methylation and/or nucleoprotein acetylation/
methylation, are crucial to the normal/physiological
development of several tissues in mammals, and they
involve several mechanisms to guarantee fluctuations of
enzymes and other proteins that regulate the metabolism
[33,34]. As previously reviewed, the intrauterine phase of
development is particularly important for the genomic
processes related to genes associated with metabolic
pathways [34-36]. Therefore, this phase of life may
be particularly important for nutritional disturbance. In
humans who experienced the Dutch famine Winter in
1944-1945 and in rats that were deprived of food
in utero, epigenetic modifications were detected in the
insulin-like growth factor 2 (IGF2) and pancreatic and
duodenal home box 1 (Pdx1), which are the major
factors involved in pancreas development and pancreatic
β-cell maturation [37,38]. Although it is known that the
pancreas and the pancreatic β-cells develop/maturate
during the embryonic phase [39], the postnatal life is
also crucial for the maintenance processes that control
the β-cell mass, such as proliferation, neogenesis and
Figure 1 Schematic model of metabolic programming resulting from a maternal low-protein diet during lactation, the “Thrifty
phenotype hypothesis” and the development of metabolic disease in late life. ANS, Autonomic nervous system.
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gramming as the result of protein-restricted diet during
lactation only have yet been reported, and no direct asso-
ciation with epigenetic modifications has been observed;
on the other hand, because stressor insults during the
milk suckling phase can lead to disturbances in glucose
metabolism, hypothalamic neurons, ANS activity and β-
cell mass/function of the pancreatic β-cells in rodents,
further studies are needed on this topic.
Nutritional restriction to the fetus: a risk of obesity onset
Two decades ago, it was observed that low birth weight
was related to adult chronic, non-transmissible diseases,
such as type 2 diabetes, cardiovascular disease and obes-
ity [2]. It has been speculated that a nutritional injury
during perinatal growth, including uterine and early
postnatal life, may contribute to adapting the adult
metabolism toward nutritional restriction. However, if
an abundant diet is offered to people who have been
undernourished during the perinatal life, this opportun-
ity induces a metabolic shift toward the storage of
energy and high fat tissue accumulation, thus leading tohigh risks of the onset of metabolic/coronary diseases
onset [1]. These observations led to the introduction of
the term DOHaD (Developmental Origins of Health and
Disease) previously known as the Barker thrifty pheno-
type hypothesis [41]. Currently, the concept of DOHaD
is extended to any other insults during perinatal life,
pregnancy and/or lactation, such as underweight, over-
weight, diabetic or hyperplasic mothers. This concept
also includes any type of stressful situations that may
predispose babies or pups to develop metabolic dis-
orders when they reach adulthood [42-47].
Food deficit in lactation does not cause obesity
Using perinatal under nutrition experimental models, it
is important to score which hallmarks are presented by
programmed organism, unless we can misunderstanding
DOHaD concepts. It is known that restricting the food
supply to a fetus may cause obesity, hyperinsulinemia
and peripheral insulin resistance, among other clinical
signals of metabolic syndrome, in adult life [2]. In con-
trast, over nutrition during lactation also induced obesity
with the same metabolic abnormalities observed in the
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nancy [48,49], and food deficiency during the lactation
period usually leads to underweight, not only in the
young but also in the adults, even when dietetic recovery
is available. Adult rats from mothers that experienced
protein restriction during lactation show impairment of
glycemic homeostasis. These programmed rats can no
longer secrete as much insulin as the rising blood glucose
levels demand [8]. However, the high insulin-sensitivity of
their tissues is able to maintain normoglycemia [50].
Similar results were found in human populations that
were poorly fed at the perinatal stage [51]. Pancreatic is-
lets isolated from programmed lean adult rats show low
glucose insulin tropic responses [52-54]. These results
demonstrate that a protein-poor diet during lactation, in
contrast to chronic protein malnutrition during the intra-
uterine and post-weaning phases, does not induce obesity
and/or diabetes but rather reduces the pancreatic β-cell
function. This adaptation allows the rat pancreas to re-
lease a low amount of insulin in response to altered meta-
bolic demand. High insulin sensitivity may further impact
the metabolism when the caloric intake increases, poten-
tially contributing to future overweight followed by the
hallmarks of metabolic syndrome, such as insulin resist-
ance [55]. Consistent with this possibility, it has been
reported that a 50% global food restriction during the last
third of pregnancy and lactation, which are crucial peri-
ods for rodent brain development, led to modifications of
the stress neuroendocrine systems, such as increased
hypothalamus-pituitary-adrenal axis activity [56] and
decreased sympathoadrenal system activity in adult male
rats under resting conditions [57]. However, when a
normal diet was offered, the adult male rats exhibited
underweight rather than obesity, suggesting that under
nutrition during lactation, at least in rodents, prevents
individuals from becoming obese. In addition, it has been
reported that prenatally undernourished rats nursed by
control mothers exhibit a rapid catch-up growth and are
more susceptible to developing obesity and features of
metabolic syndrome [58]. In contrast, the same animals,
if nursed by their own mothers, did not experience catch-
up growth and exhibited only subtle metabolic alterations
[59]. Taken together, these data indicate that lactation is
a very sensitive period that is critical to programming
the metabolism of adult rats and suggest that under
nutrition during this period may protect rats from devel-
oping obesity. However, it remains to be determined
whether this “protective” effect of under nutrition during
lactation persists in the presence of a high caloric diet or
physical inactivity.
Sex dimorphism in metabolic programming
Importantly, some dysfunctions associated with meta-
bolic programming are not similar between males andfemales. These dysfunctions are dependent not only on
the window in which the nutritional disturbance (under/
over nutrition) occurred but also on physiological differ-
ences between the genders [60-62]. As previously
reported, glucose homeostasis, insulin sensitivity, pan-
creatic β-cell function and adipose tissue depots, among
other metabolic hallmarks of adulthood, are changed by
early maternal protein restriction [63-67]. These
changes, including their magnitude, are expressed in a
different manner both in female and male rats. Protein
malnourishment during lactation causes greater insulin
sensitivity in males than in females [63,67], and this is
also observed when the protein restriction occurs during
pregnancy and lactation, which leads to higher insulin
sensitivity in males [66,67], while insulin resistance is
observed in females [65]. However, contradicting data
have also been reported [64]. Differences in glucose
homeostasis impairments are observed dependent on
gender in adult rats that were protein restricted pre-
natally; however, the period of nutritional insult is im-
portant to determine both the magnitude and the
quality of the metabolic disturbance.
Programmed metabolism and insulin secretion-coupling
process
What are the mechanisms involved in the low glucose
insulin tropic response observed in low protein-
programmed lean rats? The pancreatic β-cells secrete
insulin when stimulated mostly by glucose. However,
several nutrients, such as amino acids, fatty acids,
and their metabolites, can also stimulate cellular metabol-
ism and increase ATP production [68,69]. ATP-sensitive
potassium channels (KATP) are inactivated by an increased
ATP/ADP ratio, which provokes membrane depolariza-
tion and subsequently the activation of voltage-dependent
calcium channels [70,71]. These ionic changes increase
the intracellular calcium concentration, which is involved
in the export of insulin to the bloodstream. However,
experimental evidence indicates that glucose may also
stimulate insulin secretion by alternative pathways involv-
ing KATP channels [72]. The use of adult rats that were
protein-restricted during lactation allowed researchers
to verify whether cell metabolism and cell calcium
handling are involved in β-cell dysfunction. Although
the results showed no change in either β-cell meta-
bolism or calcium buffering, an impairment of choliner-
gic transduction was reported [73]. Surprisingly, diabetic
rats transplanted with pancreatic islets from adult rats
that were protein-restricted during lactation showed
improvement of their fasting glycemic, which may indi-
cate that changes in β-cell activity provoked by poor
perinatal protein nutrition are not permanent and could
open possibilities to new therapeutics to treat metabolic
diseases [74].
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neurotransmitters
Insulin release is modulated by non-nutrient secreta-
gogues, such as neurotransmitters, which enhance or
inhibit glucose-stimulated insulin secretion. Pancreatic
β-cells contain several receptors for neurotransmitters
and Neuropeptide, such as adrenoceptors and choliner-
gic muscarinic receptors (mAChRs). These receptors are
stimulated by efferent signals from the central nervous
system, including the ANS, throughout their neural ends
for pancreatic β-cells [75]. During blood glucose level
oscillations, the β-cells receive inputs from the para-
sympathetic and sympathetic systems to participate in
glycemic regulation. Overall, acetylcholine promotes the
potentiation of glucose-induced insulin secretion, whereas
noradrenaline and adrenaline inhibit this response [19].
Before and during food intake, vagus nerve activity is
responsible for the rise in insulin blood levels. These
effects are mediated by acetylcholine, which activates the
mAChRs in the β-cell plasma membrane. Pancreatic islets
isolated from rats that had been nursed by dams fed with
a low-protein (4-8%) diet during the first 14 days of the
lactation period showed a weak cholinergic response
[53,73]. To date, five subtypes of receptors belonging to
the muscarinic family (M1-M5) have been identified in
neurons and other cell types [76,77]. Using the RT-PCR
technique and different muscarinic antagonists, four sub-
types (M1-M4) have been shown to be present in insulin-
secreting cell lines [78], whereas other studies have shown
that 2 muscarinic subtypes (M1 and M3), and in a lesser
quantity, M5, are expressed in rat pancreatic islets [79].
Because pancreatic islets contain four different endocrine
cell types, care must be taken when dealing with the
mAChR subtypes of pancreatic β-cells. Functional studies
of mAChR subtypes have revealed that M1 and particu-
larly M3 are the receptors that are involved in the insulin
tropic effect of acetylcholine [80,81]. Interestingly, it was
reported that M3mAChR gene knockout mice are under-
weight, hypophagic and hypoinsulinemic [82], as are adult
rats that were protein-restricted during lactation. The
pancreatic islets from M3mAChR mice (-/-) showed a
reduced secretory response to cholinergic agonists [83].
Although it has not been demonstrated, it is possible that
metabolic programming induced by early protein malnu-
trition causes a reduction of M3mAChR in the pancreatic
β-cell. Recently, in studies using transgenic mice in which
the pancreatic β-cell M3mAChRs are chronically stimu-
lated, an improvement of glycemic control has been
observed, even when the mice received a high-fat diet
[84]. These data may indicate that PNS tonus, intense or
weak, can modulate β-cell function through muscarinic
receptor activities. Three-month-old male adult offspring
of mothers that received 4% protein during lactation
exhibited low PNS activity. Fasting normoglycemia andhypoinsulinemia, glucose intolerance and low plasma glu-
cose and insulin concentrations during an intravenous
glucose tolerance test were observed in the adult off-
spring of malnourished mothers [53]. In these animals,
acetylcholine or the blockage of the α2-adrenoreceptors
increased the plasma glucose and insulin concentrations,
whereas atropine or the stimulation of the α2-adrenore-
ceptors did not modify these parameters. In addition,
islets from postnatally malnourished animals exhibited
decreased insulin secretion in response to low glucose
and carbachol. By contrast, changes in the sympathetic
activity were not observed. Taken together, these data
suggest that the hypoinsulinemia observed in the adult
offspring of malnourished mothers might be caused by
alterations in the regulation of glucose-induced insulin
secretion via, in part, ANS modulation. However, other
authors using maternal protein restriction to 8% protein
during the entire lactation period concluded that the
changes in the metabolism, such as hypoinsulinemia and
low fat deposition, are due to the enhanced activity of the
sympathoadrenal axis in 180-day-old rats [85]. The dis-
crepancies between these studies might be because of
the different regimens used or because the ages of the adult
rats were different. In chronically protein-malnourished
rats, a decrease in the PNS activity and a strong increase
in the sympathetic nervous system activity were observed,
as demonstrated by recordings obtained directly from
the nerves of 90-day-old rats [25]. Recently, a low PNS
activity was observed in the adult offspring of malnour-
ished mothers, as directly recorded from the superior
vagus nerve branch, whereas the firing rates of the
sympathetic branch were unchanged [5]. Although the
recorded electrical signal of vagus nerve activity is con-
sidered to be a combination of afferent and efferent sig-
nals, the firing rates observed in this study represent part
of the electrical signal that travels from the brain to the
thoracic and visceral organs, such as the pancreas [86].
The reduced cholinergic insulin tropic response of the
pancreatic islets from metabolically programmed rats
does not suggest an up-regulation effect due to the weak
vagal activity, as expected. In contrast, studies indicate
a low secretory sensitivity to the cholinergic stimulus
in the β-cells from adult rats that were protein-
malnourished during lactation [53,73,86]. The nature of
the mAChR subfamilies that are implicated in the weak
cholinergic response of the β-cell in the offspring from
malnourished mothers is still unknown and clearly
requires further investigation.
Conclusions
To date, the body of evidence indicates that maternal
protein restriction during lactation programs the metab-
olism to reserve less energy in rat adulthood. Although
several studies have shown that perinatal nutritional
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including the hypothalamus-pituitary-adrenal axis, and
the sympathoadrenal system, little is known concerning
the PNS in this context. However, each aspect of this
system is involved in the regulation of energy metabol-
ism. We have shown that adult male rat offspring from
whose mothers were protein-restricted during lactation
exhibit a low PNS activity. Rodent lactation is a crucial
phase for brain development and could be considered
similar to the final one-third of the human gestation
period [9,87]. Although the mechanism by which protein
restriction during lactation induces permanent changes
in the metabolism is still largely unknown, evidence
suggests that ANS changes may contribute to the
impairment of glycemic homeostasis in metabolically
programmed rats. Whether these modifications of the
ANS will favor or impede the features of metabolic syn-
drome remains controversial, and this issue warrants
further investigation.
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